• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

SteadyMed Therapeutics

edit

SteadyMed Ltd. is a medical-device company pursuing innovative devices for delivering injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.

The company’s products are pre-filled drug-infusion patches that will be sold in conjunction with a series of pharma and device companies. Specific applications of the device will be tailored in accordance with the requirements of the company’s partners.

Recent Milestones

edit

• 
  SteadyMed Therapeutics received $3M in Debt funding. (4/8/13)
  Posted 4/10/13 at 4:17am via dowjones.com
• 
  SteadyMed Therapeutics received $10.4M in Venture Round funding. (9/17/12)
  Posted 9/17/12 at 6:29pm via steadymed.com
• 
  SteadyMed Therapeutics received $2M in Series A funding. (1/28/09)
  Posted 6/22/09 at 6:52am via reuters.com
• 
  SteadyMed Therapeutics added Yossi Aldar as COO.
  Posted 6/22/09 at 6:43am
• 
  SteadyMed Therapeutics added Yehuda Bachar as R&D Manager.
  Posted 6/22/09 at 6:43am
• 
  SteadyMed Therapeutics added Ian Solomon as Co-Founder & VP Business Development..
  Posted 6/22/09 at 6:43am
• 
  SteadyMed Therapeutics added Jonathan M. Rigby as CEO.
  Posted 9/13/11 at 6:45pm

Videos

Screenshots

edit

Above: SteadyMed Therapeutics Screenshot -- #1
Uploaded: 6/22/09

Sources

1. SteadyMed Closes Strategic Funding Round (reuters.com) [edit]
2. Press Release: SteadyMed Therapeutics, Inc. Raises $10.4 Million in Preferred Stock Financing. (steadymed.com) [edit]
3. SteadyMed Thera Secures $3M Loan to Advance Drug Pump to Clinical Trials (pevc.dowjones.com) [edit]